LONDON (AP) — The pharma giant AstraZeneca has requested that the European authorization for its COVID-19 vaccine be pulled, according to the EU medicines regulator.
In an update on the European Medicines Agency’s website Wednesday, the regulator said that the approval for AstraZeneca’s Vaxzevria had been withdrawn “at the request of the marketing authorization holder.”
AstraZeneca’s COVID-19 vaccine was first given the nod by the EMA in January 2021. Within weeks, however, concerns grew about the vaccine’s safety, when dozens of countries suspended the vaccine’s use after unusual but rare blood clots were detected in a small number of immunized people. The EU regulator concluded AstraZeneca’s shot didn’t raise the overall risk of clots, but doubts remained.
Partial results from its first major trial — which Britain used to authorize the vaccine — were clouded by a manufacturing mistake that researchers didn’t immediately acknowledge. Insufficient data about how well the vaccine protected older people led some countries to initially restrict its use to younger populations before reversing course.
PrettyLittleThing billionaire Umar Kamani and new wife Nada host Disney
Gordon, Jokic lead the Nuggets to the brink of a sweep with a 112
Casey DeSmith makes 30 saves as the Canucks take 2
German teams' success in Champions League disrupting Germany's Euro 2024 preparations
Korey Cunningham, a former NFL lineman, found dead in his New Jersey home. He was 28
Schneider Electric says Chinese market remains important
Yamamoto goes 8 innings and Muncy hits early slam as Dodgers beat Marlins 8
Jenifer Lewis reveals she was 'still on morphine' while performing on The Masked Singer after near
Police launch probe after man in his 20s found shot behind the wheel of a locked car
Planning for potential presidential transition underway as Biden administration kicks it off